AMN HEALTHCARE SERVICES INC (AMN) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:AMN • US0017441017

20.85 USD
-0.2 (-0.95%)
At close: Feb 5, 2026
20.85 USD
0 (0%)
After Hours: 2/5/2026, 8:09:14 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to AMN. AMN was compared to 102 industry peers in the Health Care Providers & Services industry. AMN has only an average score on both its financial health and profitability. AMN has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year AMN was profitable.
  • In the past year AMN had a positive cash flow from operations.
  • AMN had positive earnings in 4 of the past 5 years.
  • Each year in the past 5 years AMN had a positive operating cash flow.
AMN Yearly Net Income VS EBIT VS OCF VS FCFAMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

1.2 Ratios

  • AMN's Return On Assets of -12.88% is on the low side compared to the rest of the industry. AMN is outperformed by 75.49% of its industry peers.
  • The Return On Equity of AMN (-42.76%) is worse than 71.57% of its industry peers.
  • AMN has a Return On Invested Capital (2.08%) which is comparable to the rest of the industry.
  • The Average Return On Invested Capital over the past 3 years for AMN is above the industry average of 9.16%.
  • The 3 year average ROIC (13.14%) for AMN is well above the current ROIC(2.08%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -12.88%
ROE -42.76%
ROIC 2.08%
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
AMN Yearly ROA, ROE, ROICAMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

  • AMN has a Operating Margin of 1.65%. This is comparable to the rest of the industry: AMN outperforms 47.06% of its industry peers.
  • AMN's Operating Margin has declined in the last couple of years.
  • The Gross Margin of AMN (29.37%) is comparable to the rest of the industry.
  • AMN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.65%
PM (TTM) N/A
GM 29.37%
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
AMN Yearly Profit, Operating, Gross MarginsAMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • AMN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • The number of shares outstanding for AMN has been increased compared to 1 year ago.
  • The number of shares outstanding for AMN has been reduced compared to 5 years ago.
  • Compared to 1 year ago, AMN has an improved debt to assets ratio.
AMN Yearly Shares OutstandingAMN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
AMN Yearly Total Debt VS Total AssetsAMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • An Altman-Z score of 2.48 indicates that AMN is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • AMN's Altman-Z score of 2.48 is in line compared to the rest of the industry. AMN outperforms 56.86% of its industry peers.
  • The Debt to FCF ratio of AMN is 3.80, which is a good value as it means it would take AMN, 3.80 years of fcf income to pay off all of its debts.
  • AMN has a Debt to FCF ratio of 3.80. This is in the better half of the industry: AMN outperforms 72.55% of its industry peers.
  • AMN has a Debt/Equity ratio of 1.31. This is a high value indicating a heavy dependency on external financing.
  • AMN has a Debt to Equity ratio of 1.31. This is in the lower half of the industry: AMN underperforms 65.69% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.31
Debt/FCF 3.8
Altman-Z 2.48
ROIC/WACC0.26
WACC7.93%
AMN Yearly LT Debt VS Equity VS FCFAMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 1.05 indicates that AMN should not have too much problems paying its short term obligations.
  • AMN's Current ratio of 1.05 is on the low side compared to the rest of the industry. AMN is outperformed by 67.65% of its industry peers.
  • A Quick Ratio of 1.05 indicates that AMN should not have too much problems paying its short term obligations.
  • The Quick ratio of AMN (1.05) is worse than 61.76% of its industry peers.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 1.05
AMN Yearly Current Assets VS Current LiabilitesAMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • AMN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -51.29%.
  • The Earnings Per Share has been growing slightly by 0.80% on average over the past years.
  • The Revenue for AMN has decreased by -11.42% in the past year. This is quite bad
  • Measured over the past years, AMN shows a small growth in Revenue. The Revenue has been growing by 6.07% on average per year.
EPS 1Y (TTM)-51.29%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-36.07%
Revenue 1Y (TTM)-11.42%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-7.71%

3.2 Future

  • Based on estimates for the next years, AMN will show a very strong growth in Earnings Per Share. The EPS will grow by 22.82% on average per year.
  • AMN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.40% yearly.
EPS Next Y-57.99%
EPS Next 2Y-52.77%
EPS Next 3Y-29.64%
EPS Next 5Y22.82%
Revenue Next Year-8.07%
Revenue Next 2Y-6.86%
Revenue Next 3Y-3.35%
Revenue Next 5Y4.4%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AMN Yearly Revenue VS EstimatesAMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B 4B 5B
AMN Yearly EPS VS EstimatesAMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

5

4. Valuation

4.1 Price/Earnings Ratio

  • AMN is valuated reasonably with a Price/Earnings ratio of 11.03.
  • Based on the Price/Earnings ratio, AMN is valued cheaper than 86.27% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.67, AMN is valued rather cheaply.
  • The Price/Forward Earnings ratio is 28.24, which means the current valuation is very expensive for AMN.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of AMN is on the same level as its industry peers.
  • AMN is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 27.20, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.03
Fwd PE 28.24
AMN Price Earnings VS Forward Price EarningsAMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, AMN is valued cheaply inside the industry as 80.39% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, AMN is valued cheaply inside the industry as 98.04% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 3.59
EV/EBITDA 7.79
AMN Per share dataAMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

  • AMN's earnings are expected to decrease with -29.64% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)13.71
EPS Next 2Y-52.77%
EPS Next 3Y-29.64%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • AMN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AMN HEALTHCARE SERVICES INC

NYSE:AMN (2/5/2026, 8:09:14 PM)

After market: 20.85 0 (0%)

20.85

-0.2 (-0.95%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-06
Earnings (Next)02-19
Inst Owners109.44%
Inst Owner Change-3.26%
Ins Owners0.45%
Ins Owner Change9.04%
Market Cap800.85M
Revenue(TTM)2.72B
Net Income(TTM)-275.54M
Analysts69.23
Price Target20.84 (-0.05%)
Short Float %6.27%
Short Ratio2.13
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)73.35%
Min EPS beat(2)53.64%
Max EPS beat(2)93.07%
EPS beat(4)4
Avg EPS beat(4)78.74%
Min EPS beat(4)52.24%
Max EPS beat(4)116.02%
EPS beat(8)8
Avg EPS beat(8)44.14%
EPS beat(12)12
Avg EPS beat(12)33.45%
EPS beat(16)16
Avg EPS beat(16)27.33%
Revenue beat(2)1
Avg Revenue beat(2)0.79%
Min Revenue beat(2)-0.06%
Max Revenue beat(2)1.64%
Revenue beat(4)3
Avg Revenue beat(4)2.05%
Min Revenue beat(4)-0.06%
Max Revenue beat(4)4.75%
Revenue beat(8)5
Avg Revenue beat(8)1.13%
Revenue beat(12)7
Avg Revenue beat(12)1.02%
Revenue beat(16)11
Avg Revenue beat(16)1.39%
PT rev (1m)0%
PT rev (3m)-0.69%
EPS NQ rev (1m)2.3%
EPS NQ rev (3m)49.55%
EPS NY rev (1m)0%
EPS NY rev (3m)20.88%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)16.48%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.59%
Valuation
Industry RankSector Rank
PE 11.03
Fwd PE 28.24
P/S 0.29
P/FCF 3.59
P/OCF 3
P/B 1.24
P/tB N/A
EV/EBITDA 7.79
EPS(TTM)1.89
EY9.06%
EPS(NY)0.74
Fwd EY3.54%
FCF(TTM)5.8
FCFY27.82%
OCF(TTM)6.94
OCFY33.3%
SpS70.73
BVpS16.78
TBVpS-10.76
PEG (NY)N/A
PEG (5Y)13.71
Graham Number26.71
Profitability
Industry RankSector Rank
ROA -12.88%
ROE -42.76%
ROCE 2.81%
ROIC 2.08%
ROICexc 2.16%
ROICexgc 6.84%
OM 1.65%
PM (TTM) N/A
GM 29.37%
FCFM 8.2%
ROA(3y)5.5%
ROA(5y)5.99%
ROE(3y)15.7%
ROE(5y)16.78%
ROIC(3y)13.14%
ROIC(5y)12.94%
ROICexc(3y)13.46%
ROICexc(5y)13.47%
ROICexgc(3y)46.83%
ROICexgc(5y)47.63%
ROCE(3y)17.73%
ROCE(5y)17.46%
ROICexgc growth 3Y-38.44%
ROICexgc growth 5Y-11.09%
ROICexc growth 3Y-36.92%
ROICexc growth 5Y-11.74%
OM growth 3Y-31.99%
OM growth 5Y-12.8%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.13%
GM growth 5Y-1.63%
F-Score4
Asset Turnover1.27
Health
Industry RankSector Rank
Debt/Equity 1.31
Debt/FCF 3.8
Debt/EBITDA 4.12
Cap/Depr 27.3%
Cap/Sales 1.62%
Interest Coverage 0.95
Cash Conversion 129.62%
Profit Quality N/A
Current Ratio 1.05
Quick Ratio 1.05
Altman-Z 2.48
F-Score4
WACC7.93%
ROIC/WACC0.26
Cap/Depr(3y)57.01%
Cap/Depr(5y)52.87%
Cap/Sales(3y)2.35%
Cap/Sales(5y)2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-51.29%
EPS 3Y-25.55%
EPS 5Y0.8%
EPS Q2Q%-36.07%
EPS Next Y-57.99%
EPS Next 2Y-52.77%
EPS Next 3Y-29.64%
EPS Next 5Y22.82%
Revenue 1Y (TTM)-11.42%
Revenue growth 3Y-9.19%
Revenue growth 5Y6.07%
Sales Q2Q%-7.71%
Revenue Next Year-8.07%
Revenue Next 2Y-6.86%
Revenue Next 3Y-3.35%
Revenue Next 5Y4.4%
EBIT growth 1Y-66.5%
EBIT growth 3Y-38.24%
EBIT growth 5Y-7.5%
EBIT Next Year103.44%
EBIT Next 3Y20.38%
EBIT Next 5YN/A
FCF growth 1Y-48.21%
FCF growth 3Y-1.64%
FCF growth 5Y4.92%
OCF growth 1Y-49.55%
OCF growth 3Y1.61%
OCF growth 5Y7.34%

AMN HEALTHCARE SERVICES INC / AMN FAQ

What is the fundamental rating for AMN stock?

ChartMill assigns a fundamental rating of 4 / 10 to AMN.


Can you provide the valuation status for AMN HEALTHCARE SERVICES INC?

ChartMill assigns a valuation rating of 5 / 10 to AMN HEALTHCARE SERVICES INC (AMN). This can be considered as Fairly Valued.


How profitable is AMN HEALTHCARE SERVICES INC (AMN) stock?

AMN HEALTHCARE SERVICES INC (AMN) has a profitability rating of 4 / 10.


What is the earnings growth outlook for AMN HEALTHCARE SERVICES INC?

The Earnings per Share (EPS) of AMN HEALTHCARE SERVICES INC (AMN) is expected to decline by -57.99% in the next year.